Sotalol IV
Atrial Fibrillation (Loading dose for initiation of oral sotalol therapy)
Key Facts
About AltaThera Pharmaceuticals
AltaThera Pharmaceuticals is a private, precision medicine company dedicated to solving serious and costly problems in cardiovascular care through innovative science. Its core strategy utilizes model-informed drug development (MIDD) to identify new uses and optimal dosing for existing drugs, starting with its commercialized product, Sotalol IV, for atrial fibrillation. The company's mission centers on improving efficiency, effectiveness, and patient outcomes by converting inpatient procedures to outpatient, thereby reducing healthcare costs. With a team based across the country and a culture built on humility, adaptability, and intellectual curiosity, AltaThera is positioned to expand its pipeline beyond its initial cardiovascular focus.
View full company profile